Tectonic Therapeutic | AVRO - Ebit


Tectonic Therapeutic reported $-22.33M in EBIT for its fiscal quarter ending in June of 2025.





Ebit Change Date
Alnylam Pharmaceuticals USD -29.96M 34.85M Sep/2025
Celltrion KRW 301.04B 58.57B Sep/2025
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Divis Laboratories Ltd INR 7.75B 1.58B Sep/2025
Gilead Sciences USD 3.51B 810M Sep/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
MacroGenics USD 20.16M 55.51M Sep/2025
Malin Corporation EUR -1.1M 300K Dec/2024
Medical Developments International AUD -12.12M 3.97M Jun/2023
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Organigram Holdings CAD -28.05M 25.94M Sep/2025
Pfizer USD 4.57B 1.97B Sep/2025
Pharma Mar EUR -3.96M 28.11M Sep/2025
Qiagen NV USD 141.06M 6.64M Sep/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Sarepta Therapeutics USD -62.88M 178.46M Sep/2025
Sartorius EUR 150.1M 11.7M Sep/2025
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Takeda JPY 257.49B 568.56B Dec/2025
Tilray USD -20.01M 9.34M Sep/2025
Zz Pientze Pharmaceu CNY 501.33M 15.6M Sep/2025